Correlation Between Salesforce and Franklin Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Salesforce and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Franklin Biotechnology.

Diversification Opportunities for Salesforce and Franklin Biotechnology

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Salesforce and Franklin is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Salesforce i.e., Salesforce and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Salesforce and Franklin Biotechnology

Considering the 90-day investment horizon Salesforce is expected to generate 1.7 times more return on investment than Franklin Biotechnology. However, Salesforce is 1.7 times more volatile than Franklin Biotechnology Discovery. It trades about 0.1 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about 0.04 per unit of risk. If you would invest  13,334  in Salesforce on August 26, 2024 and sell it today you would earn a total of  20,868  from holding Salesforce or generate 156.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Salesforce  vs.  Franklin Biotechnology Discove

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Franklin Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Salesforce and Franklin Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Franklin Biotechnology

The main advantage of trading using opposite Salesforce and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.
The idea behind Salesforce and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges